London, 20 March 2015 – The Global Epinephrine Autoinjector Market is expected to grow at a CAGR of 13.12 percent from 2015-2019, according to a new report from research firm Technavio.
The prevalence of allergies to food items, food additives, latex, as well as associated anaphylaxis has been increasing worldwide. On average, 35 percent of the population is diagnosed with an allergy, annually. Initially, this trend was only seen in areas like the UK, Europe and the US, but it is now common in all industrially developed countries.
“Epinephrine works immediately and helps reduce the symptoms of a life-threatening allergy, which is expected to boost the market growth during the forecast period,” says Faisal Ghaus, Vice President of Technavio.
The latest report by Technavio draws attention towards the availability of improved injecting devices. Autoinjectors offer audio instructions for proper administration of the medication and are easily available in the market. It also addresses many issues like high cost, lack of reusability and needle phobia.
“Continuous product modifications and several advances in technology for the development of innovative epinephrine injectors are expected to drive the market in the positive direction through the projected period,” says Ghaus.
Technavio currently has more than 3000 market research reports on a huge range of topics, including:
https://www.technavio.com/%3Cp%3E%3Cstrong%3EAbout%20Technavio%3C/strong%…
